REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,495,583 | -70.5% | 112,746 | -73.7% | 0.00% | -75.0% |
| Q1 2023 | $38,922,488 | +404.7% | 428,096 | +110.9% | 0.00% | +300.0% |
| Q4 2022 | $7,712,388 | -4.3% | 203,011 | -36.7% | 0.00% | 0.0% |
| Q3 2022 | $8,056,000 | +198.7% | 320,536 | +261.2% | 0.00% | – |
| Q2 2022 | $2,697,000 | +5.4% | 88,741 | +13.6% | 0.00% | – |
| Q1 2022 | $2,559,000 | +1.9% | 78,132 | -17.9% | 0.00% | – |
| Q4 2021 | $2,511,000 | -71.8% | 95,218 | +7.5% | 0.00% | -100.0% |
| Q3 2021 | $8,915,000 | +5.9% | 88,611 | +49.0% | 0.00% | 0.0% |
| Q2 2021 | $8,415,000 | +2.7% | 59,453 | -27.7% | 0.00% | 0.0% |
| Q1 2021 | $8,197,000 | +1.6% | 82,229 | +26.0% | 0.00% | 0.0% |
| Q4 2020 | $8,066,000 | +35.0% | 65,258 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $5,977,000 | -40.2% | 61,353 | -4.2% | 0.00% | -50.0% |
| Q2 2020 | $9,995,000 | -27.2% | 64,052 | -32.7% | 0.00% | 0.0% |
| Q1 2020 | $13,731,000 | -26.8% | 95,132 | +3.7% | 0.00% | -33.3% |
| Q4 2019 | $18,759,000 | +163.8% | 91,766 | +3.6% | 0.00% | +200.0% |
| Q3 2019 | $7,110,000 | +19.1% | 88,554 | +40.0% | 0.00% | 0.0% |
| Q2 2019 | $5,970,000 | +6.8% | 63,274 | -3.3% | 0.00% | 0.0% |
| Q1 2019 | $5,591,000 | +33.9% | 65,418 | -12.1% | 0.00% | 0.0% |
| Q4 2018 | $4,175,000 | +411.6% | 74,432 | +646.0% | 0.00% | – |
| Q3 2018 | $816,000 | +308.0% | 9,978 | +74.0% | 0.00% | – |
| Q2 2018 | $200,000 | +55.0% | 5,734 | -9.5% | 0.00% | – |
| Q1 2018 | $129,000 | +4.0% | 6,336 | +44.7% | 0.00% | – |
| Q4 2017 | $124,000 | +125.5% | 4,378 | +148.0% | 0.00% | – |
| Q3 2017 | $55,000 | +71.9% | 1,765 | +73.9% | 0.00% | – |
| Q2 2017 | $32,000 | +23.1% | 1,015 | -9.9% | 0.00% | – |
| Q1 2017 | $26,000 | +52.9% | 1,127 | +44.1% | 0.00% | – |
| Q4 2016 | $17,000 | +183.3% | 782 | +230.0% | 0.00% | – |
| Q3 2016 | $6,000 | -98.2% | 237 | -98.6% | 0.00% | – |
| Q2 2016 | $327,000 | – | 16,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |